In one paragraphArticle in Journal of clinical medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
11 authors.
Yuran AhnDivision of Cardiology, Department of Internal Medicine, Uijeonbu St. Mary's Hospital, The Catholic University of Korea, Seoul 06591, Republic of Korea.
Ji In LeeDepartment of Clinical Research Design and Evaluation, Samsung Advanced Institute for Health Sciences & Technology (SAIHST), Sungkyunkwan University, Seoul 03063, Republic of Korea.ORCID 0000-0003-0225-5560 Han Saem JeongDr. Jeong's Heart Clinic, Jeonju 54985, Republic of Korea.
Hong-Seok LimDepartment of Cardiology, Ajou University School of Medicine, Suwon 16499, Republic of Korea.ORCID 0000-0002-3127-2071 Jin-Oh ChoiDivision of Cardiology, Department of Medicine, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Republic of Korea.
Sang-Ho JoDivision of Cardiology, Department of Internal Medicine, Hallym University Sacred Heart Hospital, Anyang 14068, Republic of Korea.
Soon Jun HongDepartment of Cardiology, Cardiovascular Center, Korea University Anam Hospital, Seoul 02841, Republic of Korea.ORCID 0000-0003-4832-6678 Hyo-Suk AhnDivision of Cardiology, Department of Internal Medicine, Uijeonbu St. Mary's Hospital, The Catholic University of Korea, Seoul 06591, Republic of Korea.ORCID 0000-0001-9531-7286 Hae Ok JungDivision of Cardiology, Department of Internal Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul 06591, Republic of Korea.ORCID 0000-0002-5102-9212 Wang Soo LeeDivision of Cardiology, Department of Internal Medicine, College of Medicine, Chung-Ang University Hospital, Seoul 06973, Republic of Korea.ORCID 0000-0002-8264-0866 Hun-Jun ParkDivision of Cardiology, Department of Internal Medicine, Uijeonbu St. Mary's Hospital, The Catholic University of Korea, Seoul 06591, Republic of Korea.ORCID 0000-0001-8009-9546 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
angiotensin receptor blockercalcium channel blockerfimasartanhypertensionmajor adverse cardiovascular events
Identifiers
PMID42882128
PMCPMC13666065
What OpenQuestion holds
Textmetadata
Read underepoch 390